Pinnacle Associates LTD United Therapeutics Corp Transaction History

Pinnacle Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$228.26 - $319.04 $11,413 - $15,952	-50 Reduced 5.21%	910 $289,000
Q1 2024 Apr 26, 2024	BUY	$210.76 - $249.51 $202,329 - $239,529	960 New	960 $220,000
Q1 2018 May 11, 2018	SELL	$107.21 - $151.94 $312,517 - $442,905	-2,915 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$118.58 - $151.28 $125,694 - $160,356	-1,060 Reduced 26.67%	2,915 $431,000
Q3 2017 Nov 13, 2017	SELL	$114.6 - $136.81 $16,044 - $19,153	-140 Reduced 3.4%	3,975 $466,000
Q2 2017 Aug 09, 2017	BUY	N/A	4,115	4,115 $534,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.